Literature DB >> 25777796

Spotlight on movement disorders: What optogenetics has to offer.

Mark A Rossi1, Nicole Calakos, Henry H Yin.   

Abstract

Elucidating the neuronal mechanisms underlying movement disorders is a major challenge because of the intricacy of the relevant neural circuits, which are characterized by diverse cell types and complex connectivity. A major limitation of traditional techniques, such as electrical stimulation or lesions, is that individual elements of a neural circuit cannot be selectively manipulated. Moreover, available treatments are largely based on trial and error rather than a detailed understanding of the circuit mechanisms. Gaps in our knowledge of the circuit mechanisms for movement disorders, as well as mechanisms underlying known treatments such as deep brain stimulation, make it difficult to design new and improved treatment options. In this perspective, we discuss how optogenetics, which allows researchers to use light to manipulate neuronal activity, can contribute to the understanding and treatment of movement disorders. We outline the advantages and limitations of optogenetics and discuss examples of studies that have used this tool to clarify the role of the basal ganglia circuitry in movement.
© 2015 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Channelrhodopsin; DBS; Parkinson's disease; dystonia

Mesh:

Year:  2015        PMID: 25777796      PMCID: PMC4397176          DOI: 10.1002/mds.26184

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  53 in total

1.  An optogenetic toolbox designed for primates.

Authors:  Ilka Diester; Matthew T Kaufman; Murtaza Mogri; Ramin Pashaie; Werapong Goo; Ofer Yizhar; Charu Ramakrishnan; Karl Deisseroth; Krishna V Shenoy
Journal:  Nat Neurosci       Date:  2011-01-30       Impact factor: 24.884

Review 2.  The subthalamic nucleus in the context of movement disorders.

Authors:  Clement Hamani; Jean A Saint-Cyr; Justin Fraser; Michael Kaplitt; Andres M Lozano
Journal:  Brain       Date:  2003-11-07       Impact factor: 13.501

3.  Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry.

Authors:  Alexxai V Kravitz; Benjamin S Freeze; Philip R L Parker; Kenneth Kay; Myo T Thwin; Karl Deisseroth; Anatol C Kreitzer
Journal:  Nature       Date:  2010-07-07       Impact factor: 49.962

4.  Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.

Authors:  Stéphane Palfi; Jean Marc Gurruchaga; G Scott Ralph; Helene Lepetit; Sonia Lavisse; Philip C Buttery; Colin Watts; James Miskin; Michelle Kelleher; Sarah Deeley; Hirokazu Iwamuro; Jean Pascal Lefaucheur; Claire Thiriez; Gilles Fenelon; Cherry Lucas; Pierre Brugières; Inanna Gabriel; Kou Abhay; Xavier Drouot; Naoki Tani; Aurelie Kas; Bijan Ghaleh; Philippe Le Corvoisier; Patrice Dolphin; David P Breen; Sarah Mason; Natalie Valle Guzman; Nicholas D Mazarakis; Pippa A Radcliffe; Richard Harrop; Susan M Kingsman; Olivier Rascol; Stuart Naylor; Roger A Barker; Philippe Hantraye; Philippe Remy; Pierre Cesaro; Kyriacos A Mitrophanous
Journal:  Lancet       Date:  2014-01-10       Impact factor: 79.321

Review 5.  Mouse transgenic approaches in optogenetics.

Authors:  Hongkui Zeng; Linda Madisen
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

6.  Millisecond-timescale optical control of neural dynamics in the nonhuman primate brain.

Authors:  Xue Han; Xiaofeng Qian; Jacob G Bernstein; Hui-Hui Zhou; Giovanni Talei Franzesi; Patrick Stern; Roderick T Bronson; Ann M Graybiel; Robert Desimone; Edward S Boyden
Journal:  Neuron       Date:  2009-04-30       Impact factor: 17.173

7.  The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism.

Authors:  T Wichmann; H Bergman; M R DeLong
Journal:  J Neurophysiol       Date:  1994-08       Impact factor: 2.714

8.  Channelrhodopsin-2, a directly light-gated cation-selective membrane channel.

Authors:  Georg Nagel; Tanjef Szellas; Wolfram Huhn; Suneel Kateriya; Nona Adeishvili; Peter Berthold; Doris Ollig; Peter Hegemann; Ernst Bamberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-13       Impact factor: 11.205

9.  Start/stop signals emerge in nigrostriatal circuits during sequence learning.

Authors:  Xin Jin; Rui M Costa
Journal:  Nature       Date:  2010-07-22       Impact factor: 49.962

10.  Targeting cells with single vectors using multiple-feature Boolean logic.

Authors:  Lief E Fenno; Joanna Mattis; Charu Ramakrishnan; Minsuk Hyun; Soo Yeun Lee; Miao He; Jason Tucciarone; Aslihan Selimbeyoglu; Andre Berndt; Logan Grosenick; Kelly A Zalocusky; Hannah Bernstein; Haley Swanson; Chelsey Perry; Ilka Diester; Frederick M Boyce; Caroline E Bass; Rachael Neve; Z Josh Huang; Karl Deisseroth
Journal:  Nat Methods       Date:  2014-06-08       Impact factor: 28.547

View more
  6 in total

Review 1.  Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology.

Authors:  Rachel J Sizemore; Sonja Seeger-Armbruster; Stephanie M Hughes; Louise C Parr-Brownlie
Journal:  J Neurophysiol       Date:  2016-02-17       Impact factor: 2.714

Review 2.  Synaptic plasticity may underlie l-DOPA induced dyskinesia.

Authors:  Anders Borgkvist; Ori J Lieberman; David Sulzer
Journal:  Curr Opin Neurobiol       Date:  2017-11-07       Impact factor: 6.627

Review 3.  Light-induced regulation of ligand-gated channel activity.

Authors:  Piotr Bregestovski; Galyna Maleeva; Pau Gorostiza
Journal:  Br J Pharmacol       Date:  2017-10-06       Impact factor: 8.739

4.  Analyzing 7000 texts on deep brain stimulation: what do they tell us?

Authors:  Christian Ineichen; Markus Christen
Journal:  Front Integr Neurosci       Date:  2015-10-26

Review 5.  New Targets and New Technologies in the Treatment of Parkinson's Disease: A Narrative Review.

Authors:  Nicola Montemurro; Nelida Aliaga; Pablo Graff; Amanda Escribano; Jafeth Lizana
Journal:  Int J Environ Res Public Health       Date:  2022-07-20       Impact factor: 4.614

Review 6.  Genetic manipulation for inherited neurodegenerative diseases: myth or reality?

Authors:  Patrick Yu-Wai-Man
Journal:  Br J Ophthalmol       Date:  2016-03-21       Impact factor: 4.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.